资讯

Aclaris Therapeutics Announces Late-Breaking Abstract and Oral Presentation On ATI-2138 ...

Late Breaking Abstract to Present Additional Data from Aclaris’ Phase 2a Trial of ATI-2138 in Atopic Dermatitis- WAYNE, Pa., ...

Kymera Therapeutics, Inc. (KYMR) Presents At Morgan Stanley 23rd Annual Global Healthcare ...

Kymera Therapeutics, Inc. ( NASDAQ: KYMR) Morgan Stanley 23rd Annual Global Healthcare Conference September 9, 2025 12:20 PM EDT ...

ProKidney Corp. (PROK) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference ...

ProKidney Corp. ( NASDAQ: PROK) Morgan Stanley 23rd Annual Global Healthcare Conference September 8, 2025 7:00 AM EDT ...